Non-drug therapy to reduce long-term cough in lung scarring
Part of Lungs & breathing clinical trials.
This study tests a non-medication cough-control program for people who have lung scarring (interstitial lung disease) and a cough lasting more than 8 weeks. It may help you control coughing better without adding new medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of interstitial lung disease (ILD) from a doctor
- Your cough has lasted longer than 8 weeks
- You do not have moderate or large amounts of phlegm/sputum most days
- You have not had a recent worsening of your lung condition in the past month
- You have not had a cold or upper respiratory infection in the past month
- You can read/speak English and give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses analysis of mucus (sputum) to guide treatment with the goal of reducing long-lasting cough in adults with interstitial lung disease (ILD). You may be asked to provide sputum samples and may receive treatment decisions based on those results.
This trial is testing a telehealth program (using phone calls or video meetings) to help people with interstitial lung disease manage chronic cough. If you join, you'll get guidance and support to improve your cough symptoms and quality of life.
This Phase 2 study tests whether two different doses of duloxetine and amitriptyline can reduce coughing caused by interstitial lung disease (ILD). If you have had a long-lasting ILD-related cough despite stable ILD treatment, this trial may help find a better way to control your cough.
This study tests two cough-relief medicines, gabapentin and benzonatate, against usual care in people with interstitial lung disease (lung scarring) who have had a chronic cough for at least 8 weeks. It aims to see which option works better and is safer.
This study tests a behavior-based therapy to help you gain control over a persistent cough that hasn't responded to other treatments. You will learn techniques to reduce coughing during a 4-week program.
This trial tests a behavioral therapy for people whose chronic cough (lasting more than 8 weeks) hasn't improved with usual treatments like asthma or reflux medicine. You may join if your cough is triggered by things like talking, laughing, cold air, or irritants, and you have throat symptoms like irritation or hoarseness.
Hear when a new Cough trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.